01 1Auro Peptides Limited
01 1LINACLOTIDE
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2015-12-04
Pay. Date : 2015-09-18
DMF Number : 29708
Submission : 2015-09-22
Status : Active
Type : II
20
Auro Peptides Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is LINACLOTIDE, with a corresponding US DMF Number 29708.
Remarkably, this DMF maintains an Active status since its submission on September 22, 2015, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of December 04, 2015, and payment made on September 18, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II
